| 941678-49-5 Basic information More.. |
Product Name: | Ruxolitinib | Synonyms: | (betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile;(3R)-3-(4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile;(3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyriMidin-4-yl}-1H-pyrazol-1-yl)propanenitrile;INCB018424 (Ruxolitinib);β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-(βR)-1H-pyrazole-1-propanenitrile;(βR)-β-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-1H-pyrazole-1-propanenitrile;Ruxolitinib(INCB-018424);1H-Pyrazole-1-propanenitrile,.beta.-cyclopentyl-4-(7H-pyrrolo[2,3-d]pyriMidin-4-yl)-,(.beta.R)- | CAS: | 941678-49-5 | MF: | C17H18N6 | MW: | 306.37 | EINECS: | 1312995-182-4 | Mol File: | 941678-49-5.mol | ![941678-49-5](/CAS/GIF/941678-49-5.gif) |
Use
Ruxolitinib is a small-molecule inhibitor of the tyrosine kinase (namely, jak1 and jak2) and is suitable for the treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis and post essential thrombocythemia myelofibrosis.
- Ruxolitinib
-
- US $254.00 / g/Bag
- 2024-08-20
- CAS:941678-49-5
- Min. Order: 1g
- Purity: 98%
- Supply Ability: 10kg
- Ruxolitinib
-
- US $0.00 / kg
- 2024-04-29
- CAS:941678-49-5
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 10000kg
- Ruxolitinib
-
- US $0.00-0.00 / Kg
- 2024-04-09
- CAS:941678-49-5
- Min. Order: 1Kg
- Purity: 99.9%
- Supply Ability: 200tons
|
941678-49-5
Recommend Suppliers |
|